Related Experiment Videos
Scleredema and diabetic sclerodactyly
Lisa Moed Gruson1, Andrew Franks
1Department of Dermatology, New York University School of Medicine, USA.
Dermatology Online Journal
|January 13, 2006
Summary
This case study highlights a rare skin condition in a patient with long-standing insulin-dependent diabetes mellitus. Early differentiation from scleroderma and exploring various treatment options are crucial for managing this diabetic complication.
Area of Science:
- Dermatology
- Endocrinology
- Pathology
Background:
- Diabetes mellitus is a common endocrine disorder with various cutaneous manifestations.
- Scleredema and diabetic sclerodactyly are known skin complications associated with diabetes.
- Accurate differentiation from scleroderma is essential for appropriate patient management.
Observation:
- A 40-year-old male with a history of insulin-dependent diabetes mellitus presented with progressive hardening of the skin on his hands and upper back.
- Histopathology revealed a thickened reticular dermis with haphazard collagen bundles and increased connective tissue mucin deposits.
- The clinical and histopathological findings suggested a diagnosis of scleredema diabeticorum.
Findings:
- The patient's skin biopsy demonstrated characteristic features of scleredema, distinct from scleroderma.
- Effective management of such diabetic skin conditions often requires a multi-modal therapeutic approach.
- This case underscores the importance of recognizing and differentiating specific diabetic dermatoses.
Implications:
- Early and accurate diagnosis of diabetic skin complications can prevent misdiagnosis and guide treatment.
- Understanding the histopathological nuances is key to distinguishing scleredema from other fibrotic skin conditions.
- Exploring diverse treatment modalities, including aminobenzoate, colchicine, and DMSO gel, may offer therapeutic benefits for refractory cases.